Improve Medical Instruments Co., Ltd. (SHE:300030)
China · Delayed Price · Currency is CNY 8.35
+0.16 (1.95%)
Jan 23, 2026, 3:04 PM CST
SHE:300030 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -51.34 | -117.9 | -63.2 | -198.3 | 18.57 | 162.52 | Upgrade |
Depreciation & Amortization | 39.85 | 39.85 | 45.13 | 46.75 | 53.31 | 37.48 | Upgrade |
Other Amortization | 2.03 | 2.03 | 3.58 | 2.67 | 2.63 | 3.15 | Upgrade |
Loss (Gain) From Sale of Assets | -0.9 | -0.9 | -6.45 | -0.44 | -0.02 | 0.17 | Upgrade |
Asset Writedown & Restructuring Costs | 23.33 | 23.33 | 8.99 | 90.08 | 1.39 | 3.8 | Upgrade |
Loss (Gain) From Sale of Investments | 63.56 | 63.56 | -7.44 | 53.1 | -19.34 | -82.91 | Upgrade |
Provision & Write-off of Bad Debts | 23.96 | 23.96 | -3.08 | 9.1 | 7.75 | 46.1 | Upgrade |
Other Operating Activities | -3.49 | 34.52 | 47.92 | 53.47 | 44.18 | 37.92 | Upgrade |
Change in Accounts Receivable | 19.6 | 19.6 | 52.76 | -12.59 | 109.82 | -77.45 | Upgrade |
Change in Inventory | -0.09 | -0.09 | -19.77 | -16.14 | -15.78 | -73.41 | Upgrade |
Change in Accounts Payable | -1.92 | -1.92 | 6.97 | 38.21 | -32.99 | 97.43 | Upgrade |
Operating Cash Flow | 110.39 | 81.84 | 79.9 | 42.48 | 171.74 | 141.27 | Upgrade |
Operating Cash Flow Growth | 25.08% | 2.42% | 88.11% | -75.27% | 21.56% | 187.36% | Upgrade |
Capital Expenditures | -19.91 | -51.28 | -43.7 | -58.04 | -71.05 | -56.82 | Upgrade |
Sale of Property, Plant & Equipment | 1.66 | 37.51 | 3.6 | 0.06 | 0.13 | 0.08 | Upgrade |
Divestitures | - | - | - | 26.6 | 2.71 | - | Upgrade |
Investment in Securities | 13 | 28.35 | -20 | -13.25 | 5.79 | -6.75 | Upgrade |
Other Investing Activities | -14 | -1.08 | 21.59 | - | 22.62 | 2.19 | Upgrade |
Investing Cash Flow | -19.24 | 13.5 | -38.5 | -44.64 | -39.81 | -61.3 | Upgrade |
Long-Term Debt Issued | - | 354.73 | 393.58 | 381.99 | 272.62 | 279.69 | Upgrade |
Long-Term Debt Repaid | - | -405.57 | -425.18 | -467.2 | -250.39 | -308.84 | Upgrade |
Net Debt Issued (Repaid) | -186.59 | -50.84 | -31.6 | -85.21 | 22.24 | -29.15 | Upgrade |
Issuance of Common Stock | 0.03 | 0.03 | - | - | 9.91 | 25.11 | Upgrade |
Repurchase of Common Stock | - | - | - | - | - | -24.91 | Upgrade |
Common Dividends Paid | -9.75 | -11.97 | -15.94 | -37.67 | -31.14 | -26.79 | Upgrade |
Other Financing Activities | 2.03 | 2.14 | -2.56 | 2.05 | -3.57 | -2.58 | Upgrade |
Financing Cash Flow | -194.28 | -60.63 | -50.09 | -120.83 | -2.57 | -58.32 | Upgrade |
Foreign Exchange Rate Adjustments | 0.94 | 1.23 | 0.61 | 0.98 | -0.88 | -2.37 | Upgrade |
Net Cash Flow | -102.2 | 35.94 | -8.08 | -122.01 | 128.49 | 19.29 | Upgrade |
Free Cash Flow | 90.48 | 30.55 | 36.2 | -15.56 | 100.69 | 84.46 | Upgrade |
Free Cash Flow Growth | 430.02% | -15.60% | - | - | 19.22% | - | Upgrade |
Free Cash Flow Margin | 17.77% | 5.26% | 5.62% | -2.19% | 12.59% | 9.19% | Upgrade |
Free Cash Flow Per Share | 0.29 | 0.10 | 0.12 | -0.05 | 0.33 | 0.28 | Upgrade |
Cash Income Tax Paid | 22.46 | 26.21 | 22.48 | 30.03 | 47.81 | 38.4 | Upgrade |
Levered Free Cash Flow | 83.61 | 52 | 11.4 | -9.78 | 42.7 | 32.15 | Upgrade |
Unlevered Free Cash Flow | 87.24 | 58.93 | 21.76 | 2.53 | 58.61 | 47.58 | Upgrade |
Change in Working Capital | 13.4 | 13.4 | 54.48 | -13.94 | 63.26 | -66.96 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.